secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2026-07-02T21:07:26+00:00
Accession:  0000950103-26-010195
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics grants $2.9M cash and 1.1M RSU retention awards to CEO, CFO, CMO
--------------------------------------------------------------------------------

- CEO Ameet Mallik receives $1,795,500 cash and 675,000 RSUs; CFO Jose Carmona $541,842 cash and 203,700 RSUs; CMO Mohamed Zaki $568,974 cash and 213,900 RSUs.
- Cash awards payable July 15, 2026; subject to repayment if employment ends before June 30, 2027 (exceptions for termination without cause or for good reason).
- RSUs vest on June 30, 2027 or earlier upon termination without cause or for good reason, subject to continued employment.
- Awards approved by Board with advice of independent compensation consultant on June 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/0000950103-26-010195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/dp249055_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-26-010195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer